Marjaana Koponen

2.2k total citations
81 papers, 1.6k citations indexed

About

Marjaana Koponen is a scholar working on Psychiatry and Mental health, Geriatrics and Gerontology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Marjaana Koponen has authored 81 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Psychiatry and Mental health, 29 papers in Geriatrics and Gerontology and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Marjaana Koponen's work include Dementia and Cognitive Impairment Research (34 papers), Pharmaceutical Practices and Patient Outcomes (26 papers) and Schizophrenia research and treatment (26 papers). Marjaana Koponen is often cited by papers focused on Dementia and Cognitive Impairment Research (34 papers), Pharmaceutical Practices and Patient Outcomes (26 papers) and Schizophrenia research and treatment (26 papers). Marjaana Koponen collaborates with scholars based in Finland, Sweden and Australia. Marjaana Koponen's co-authors include Sirpa Hartikainen, Anna‐Maija Tolppanen, Heidi Taipale, Antti Tanskanen, Jari Tiihonen, J. Simon Bell, Piia Lavikainen, Riitta Ahonen, Sarah N. Hilmer and Sirpa Hartikainen and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

Marjaana Koponen

77 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marjaana Koponen Finland 24 762 520 213 205 198 81 1.6k
Philip E. Lee Canada 12 937 1.2× 374 0.7× 154 0.7× 225 1.1× 169 0.9× 20 1.6k
Piia Lavikainen Finland 22 425 0.6× 558 1.1× 242 1.1× 314 1.5× 244 1.2× 78 1.5k
Che‐Sheng Chu Taiwan 24 653 0.9× 518 1.0× 562 2.6× 242 1.2× 131 0.7× 99 2.3k
Ugo Lucca Italy 24 539 0.7× 357 0.7× 564 2.6× 142 0.7× 190 1.0× 75 2.2k
Claire Chiang United States 17 939 1.2× 308 0.6× 92 0.4× 188 0.9× 136 0.7× 33 1.5k
Sara García‐Ptacek Sweden 29 1.0k 1.3× 347 0.7× 453 2.1× 197 1.0× 269 1.4× 100 2.3k
Fred Unverzagt United States 27 1.3k 1.7× 353 0.7× 511 2.4× 115 0.6× 342 1.7× 40 2.8k
Mei Sian Chong Singapore 27 765 1.0× 403 0.8× 588 2.8× 141 0.7× 176 0.9× 75 2.0k
Margaret A. Kirshner United States 26 946 1.2× 391 0.8× 120 0.6× 91 0.4× 297 1.5× 40 2.1k
Lori A. Daiello United States 20 345 0.5× 283 0.5× 288 1.4× 159 0.8× 267 1.3× 83 1.7k

Countries citing papers authored by Marjaana Koponen

Since Specialization
Citations

This map shows the geographic impact of Marjaana Koponen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjaana Koponen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjaana Koponen more than expected).

Fields of papers citing papers by Marjaana Koponen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjaana Koponen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjaana Koponen. The network helps show where Marjaana Koponen may publish in the future.

Co-authorship network of co-authors of Marjaana Koponen

This figure shows the co-authorship network connecting the top 25 collaborators of Marjaana Koponen. A scholar is included among the top collaborators of Marjaana Koponen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjaana Koponen. Marjaana Koponen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koponen, Marjaana, et al.. (2025). Bipolar Disorder as a Long‐Term Risk Factor for Parkinson's Disease: A Nationwide Case–Control Study. Movement Disorders. 41(3). 690–698. 1 indexed citations
2.
Tiihonen, Miia, et al.. (2025). Long‐Term Use of Benzodiazepines and Related Drugs in Persons With Major Depressive Disorder. Brain and Behavior. 15(11). e71085–e71085.
3.
Koponen, Marjaana, et al.. (2023). Real-world effectiveness of antidepressant use in persons with schizophrenia: within-individual study of 61,889 subjects. Schizophrenia. 9(1). 34–34. 8 indexed citations
4.
Koponen, Marjaana, et al.. (2022). Real‐world effectiveness of mood stabilizer use in schizophrenia. Acta Psychiatrica Scandinavica. 147(3). 257–266. 11 indexed citations
5.
Koponen, Marjaana, et al.. (2022). Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease. Neurology. 98(12). e1273–e1281. 17 indexed citations
6.
Pisa, Federica, Piia Lavikainen, Marjaana Koponen, et al.. (2021). Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer’s Disease. Clinical Epidemiology. Volume 13. 295–307. 4 indexed citations
7.
Vu, Mai, Marjaana Koponen, Heidi Taipale, et al.. (2021). Coronary Revascularization and Postoperative Outcomes in People With and Without Alzheimer’s Disease. The Journals of Gerontology Series A. 76(8). 1524–1530. 3 indexed citations
8.
Hartikainen, Sirpa, et al.. (2021). Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer's disease. International Journal of Geriatric Psychiatry. 36(7). 1075–1084. 5 indexed citations
9.
Tolppanen, Anna‐Maija, Marjaana Koponen, Heidi Taipale, et al.. (2021). Does Recent Hospitalization Increase Antipsychotic Initiation Among Community Dwellers With Alzheimer's Disease?. Journal of the American Medical Directors Association. 22(7). 1543–1547.e3. 6 indexed citations
10.
Koponen, Marjaana, et al.. (2020). Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia. European Journal of Clinical Pharmacology. 76(5). 711–718. 12 indexed citations
11.
Taipale, Heidi, Jaana Rysä, Janne Hukkanen, et al.. (2019). Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer’s disease—nested case-control study. Osteoporosis International. 30(7). 1481–1489. 4 indexed citations
12.
Taipale, Heidi, Anna‐Maija Tolppanen, Antti Tanskanen, et al.. (2018). Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer’s disease. European Journal of Clinical Pharmacology. 75(3). 417–425. 8 indexed citations
13.
Tolppanen, Anna‐Maija, Marjaana Koponen, Antti Tanskanen, et al.. (2018). Proton pump inhibitor use and risk of hip fractures among community-dwelling persons with Alzheimer's disease-a nested case-control study. UEF eRepo (University of Eastern Finland). 1 indexed citations
14.
Tolppanen, Anna‐Maija, Marjaana Koponen, Antti Tanskanen, et al.. (2018). Proton pump inhibitor use and risk of hip fractures among community‐dwelling persons with Alzheimer's disease—a nested case‐control study. Alimentary Pharmacology & Therapeutics. 47(8). 1135–1142. 17 indexed citations
15.
Koponen, Marjaana, Heidi Taipale, Piia Lavikainen, et al.. (2017). Antipsychotic Use And The Risk Of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari).
16.
Taipale, Heidi, Marjaana Koponen, Antti Tanskanen, et al.. (2017). Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer’s disease: a nationwide matched cohort study. Alzheimer s Research & Therapy. 9(1). 59–59. 8 indexed citations
17.
Taipale, Heidi, Marjaana Koponen, Antti Tanskanen, et al.. (2016). Drug use in persons with and without Alzheimer's disease aged 90 years or more. Age and Ageing. 45(6). 900–904. 12 indexed citations
18.
Koponen, Marjaana, Heidi Taipale, Antti Tanskanen, et al.. (2015). Long-term use of antipsychotics among community-dwelling persons with Alzheimer׳s disease: A nationwide register-based study. European Neuropsychopharmacology. 25(10). 1706–1713. 25 indexed citations
19.
Koponen, Marjaana, Heidi Taipale, Antti Tanskanen, et al.. (2015). Long-term use of antipsychotics among community-dwelling persons with Alzheimer's disease: A nationwide register-based study. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations
20.
Taipale, Heidi, Marjaana Koponen, Antti Tanskanen, et al.. (2014). High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort. WOS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip E. Lee Breakdown of academic impact, for papers by Piia Lavikainen Breakdown of academic impact, for papers by Che‐Sheng Chu Breakdown of academic impact, for papers by Ugo Lucca Breakdown of academic impact, for papers by Claire Chiang Breakdown of academic impact, for papers by Sara García‐Ptacek Breakdown of academic impact, for papers by Fred Unverzagt Breakdown of academic impact, for papers by Mei Sian Chong Breakdown of academic impact, for papers by Margaret A. Kirshner Breakdown of academic impact, for papers by Lori A. Daiello
Rankless by CCL
2026